Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

Articles published in
PLoS Med
    January 2018
  1. MARRAZZO JM, Dombrowski JC, Mayer KH
    Sexually transmitted infections in the era of antiretroviral-based HIV prevention: Priorities for discovery research, implementation science, and community involvement.
    PLoS Med. 2018;15:e1002485.
    >> Share

    December 2017
  2. DUBE K, Sylla L, Dee L, Taylor J, et al
    Research on HIV cure: Mapping the ethics landscape.
    PLoS Med. 2017;14:e1002470.
    >> Share

  3. KENDALL EA, Schumacher SG, Denkinger CM, Dowdy DW, et al
    Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling study.
    PLoS Med. 2017;14:e1002472.
    >> Share

  4. SUTHAR AB, Barnighausen T
    Antiretroviral therapy and population mortality: Leveraging routine national data to advance policy.
    PLoS Med. 2017;14:e1002469.
    >> Share

  5. JOHNSON LF, May MT, Dorrington RE, Cornell M, et al
    Estimating the impact of antiretroviral treatment on adult mortality trends in South Africa: A mathematical modelling study.
    PLoS Med. 2017;14:e1002468.
    >> Share

  6. CHESANG K, Hornston S, Muhenje O, Saliku T, et al
    Healthcare provider perspectives on managing sexually transmitted infections in HIV care settings in Kenya: A qualitative thematic analysis.
    PLoS Med. 2017;14:e1002480.
    >> Share

  7. WILSON E, Free C, Morris TP, Syred J, et al
    Internet-accessed sexually transmitted infection (e-STI) testing and results service: A randomised, single-blind, controlled trial.
    PLoS Med. 2017;14:e1002479.
    >> Share

  8. JOHNSTON C, Magaret A, Roychoudhury P, Greninger AL, et al
    Dual-strain genital herpes simplex virus type 2 (HSV-2) infection in the US, Peru, and 8 countries in sub-Saharan Africa: A nested cross-sectional viral genotyping study.
    PLoS Med. 2017;14:e1002475.
    >> Share

    November 2017
  9. CASTILLO P, Hurtado JC, Martinez MJ, Jordao D, et al
    Validity of a minimally invasive autopsy for cause of death determination in maternal deaths in Mozambique: An observational study.
    PLoS Med. 2017;14:e1002431.
    >> Share

  10. MCNAIRY ML, Lamb MR, Gachuhi AB, Nuwagaba-Biribonwoha H, et al
    Effectiveness of a combination strategy for linkage and retention in adult HIV care in Swaziland: The Link4Health cluster randomized trial.
    PLoS Med. 2017;14:e1002420.
    >> Share

  11. BOYD MA, Mocroft A, Ryom L, Monforte AD, et al
    Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study.
    PLoS Med. 2017;14:e1002424.
    >> Share

  12. HENRICH TJ, Hatano H, Bacon O, Hogan LE, et al
    HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.
    PLoS Med. 2017;14:e1002417.
    >> Share

  13. KAPLAN SR, Oosthuizen C, Stinson K, Little F, et al
    Contemporary disengagement from antiretroviral therapy in Khayelitsha, South Africa: A cohort study.
    PLoS Med. 2017;14:e1002407.
    >> Share

  14. EL-SADR WM, Harripersaud K, Rabkin M
    Reaching global HIV/AIDS goals: What got us here, won't get us there.
    PLoS Med. 2017;14:e1002421.
    >> Share

  15. POTEAT T, Ackerman B, Diouf D, Ceesay N, et al
    HIV prevalence and behavioral and psychosocial factors among transgender women and cisgender men who have sex with men in 8 African countries: A cross-sectional analysis.
    PLoS Med. 2017;14:e1002422.
    >> Share

  16. MAYER KH, Seaton KE, Huang Y, Grunenberg N, et al
    Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial.
    PLoS Med. 2017;14:e1002435.
    >> Share

  17. SZUBERT AJ, Prendergast AJ, Spyer MJ, Musiime V, et al
    Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial.
    PLoS Med. 2017;14:e1002432.
    >> Share

  18. MORRIS L, Mkhize NN
    Prospects for passive immunity to prevent HIV infection.
    PLoS Med. 2017;14:e1002436.
    >> Share

  19. KATZ IT, Kaplan R, Fitzmaurice G, Leone D, et al
    Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study.
    PLoS Med. 2017;14:e1002434.
    >> Share

  20. ELUL B, Lamb MR, Lahuerta M, Abacassamo F, et al
    A combination intervention strategy to improve linkage to and retention in HIV care following diagnosis in Mozambique: A cluster-randomized study.
    PLoS Med. 2017;14:e1002433.
    >> Share

  21. BARNABAS RV, Celum C
    Closing the gaps in the HIV care continuum.
    PLoS Med. 2017;14:e1002443.
    >> Share

  22. DUNNING L, Francke JA, Mallampati D, MacLean RL, et al
    The value of confirmatory testing in early infant HIV diagnosis programmes in South Africa: A cost-effectiveness analysis.
    PLoS Med. 2017;14:e1002446.
    >> Share

  23. CHANDA MM, Ortblad KF, Mwale M, Chongo S, et al
    HIV self-testing among female sex workers in Zambia: A cluster randomized controlled trial.
    PLoS Med. 2017;14:e1002442.
    >> Share

  24. EAKLE R, Gomez GB, Naicker N, Bothma R, et al
    HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project.
    PLoS Med. 2017;14:e1002444.
    >> Share

  25. DEEKS SG, Lewin SR, Bekker LG
    The end of HIV: Still a very long way to go, but progress continues.
    PLoS Med. 2017;14:e1002466.
    >> Share

  26. BOR J, Fox MP, Rosen S, Venkataramani A, et al
    Treatment eligibility and retention in clinical HIV care: A regression discontinuity study in South Africa.
    PLoS Med. 2017;14:e1002463.
    >> Share

  27. SOLOMON SS, McFall AM, Lucas GM, Srikrishnan AK, et al
    Respondent-driven sampling for identification of HIV- and HCV-infected people who inject drugs and men who have sex with men in India: A cross-sectional, community-based analysis.
    PLoS Med. 2017;14:e1002460.
    >> Share

  28. ORTBLAD K, Kibuuka Musoke D, Ngabirano T, Nakitende A, et al
    Direct provision versus facility collection of HIV self-tests among female sex workers in Uganda: A cluster-randomized controlled health systems trial.
    PLoS Med. 2017;14:e1002458.
    >> Share

  29. CUMMINS NW, Rizza S, Litzow MR, Hua S, et al
    Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study.
    PLoS Med. 2017;14:e1002461.
    >> Share

  30. BEYRER C, Wirtz AL, O'Hara G, Leon N, et al
    The expanding epidemic of HIV-1 in the Russian Federation.
    PLoS Med. 2017;14:e1002462.
    >> Share

    August 2017
  31. DE NEVE JW, Garrison-Desany H, Andrews KG, Sharara N, et al
    Harmonization of community health worker programs for HIV: A four-country qualitative study in Southern Africa.
    PLoS Med. 2017;14:e1002374.
    >> Share

  32. MYER L, Essajee S, Broyles LN, Watts DH, et al
    Pregnant and breastfeeding women: A priority population for HIV viral load monitoring.
    PLoS Med. 2017;14:e1002375.
    >> Share

    July 2017
  33. KARWA R, Maina M, Mercer T, Njuguna B, et al
    Leveraging peer-based support to facilitate HIV care in Kenya.
    PLoS Med. 2017;14:e1002355.
    >> Share

  34. ALIROL E, Wi TE, Bala M, Bazzo ML, et al
    Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines.
    PLoS Med. 2017;14:e1002366.
    >> Share

  35. KOENIG SP, Dorvil N, Devieux JG, Hedt-Gauthier BL, et al
    Same-day HIV testing with initiation of antiretroviral therapy versus standard care for persons living with HIV: A randomized unblinded trial.
    PLoS Med. 2017;14:e1002357.
    >> Share

  36. SIMMS V, Dauya E, Dakshina S, Bandason T, et al
    Community burden of undiagnosed HIV infection among adolescents in Zimbabwe following primary healthcare-based provider-initiated HIV testing and counselling: A cross-sectional survey.
    PLoS Med. 2017;14:e1002360.
    >> Share

  37. GENG EH, Havlir DV
    The science of rapid start-From the when to the how of antiretroviral initiation.
    PLoS Med. 2017;14:e1002358.
    >> Share

  38. LIGHTFOOT M, Dunbar M, Weiser SD
    Reducing undiagnosed HIV infection among adolescents in sub-Saharan Africa: Provider-initiated and opt-out testing are not enough.
    PLoS Med. 2017;14:e1002361.
    >> Share

    June 2017
  39. MAHEU-GIROUX M, Vesga JF, Diabate S, Alary M, et al
    Population-level impact of an accelerated HIV response plan to reach the UNAIDS 90-90-90 target in Cote d'Ivoire: Insights from mathematical modeling.
    PLoS Med. 2017;14:e1002321.
    >> Share

  40. TAYLOR M, Newman L, Ishikawa N, Laverty M, et al
    Elimination of mother-to-child transmission of HIV and Syphilis (EMTCT): Process, progress, and program integration.
    PLoS Med. 2017;14:e1002329.
    >> Share

    May 2017
  41. HAYES R, Floyd S, Schaap A, Shanaube K, et al
    A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial.
    PLoS Med. 2017;14:e1002292.
    >> Share

  42. IWUJI C, Newell ML
    Towards control of the global HIV epidemic: Addressing the middle-90 challenge in the UNAIDS 90-90-90 target.
    PLoS Med. 2017;14:e1002293.
    >> Share

  43. BERNARD CL, Owens DK, Goldhaber-Fiebert JD, Brandeau ML, et al
    Estimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: A model-based analysis.
    PLoS Med. 2017;14:e1002312.
    >> Share

    April 2017
  44. GRANICH R, Gupta S, Hall I, Aberle-Grasse J, et al
    Status and methodology of publicly available national HIV care continua and 90-90-90 targets: A systematic review.
    PLoS Med. 2017;14:e1002253.
    >> Share

  45. FOX MP, Rosen S
    A new cascade of HIV care for the era of "treat all".
    PLoS Med. 2017;14:e1002268.
    >> Share

  46. SHARMA M, Barnabas RV, Celum C
    Community-based strategies to strengthen men's engagement in the HIV care cascade in sub-Saharan Africa.
    PLoS Med. 2017;14:e1002262.
    >> Share

  47. MCNAIRY ML, Abrams EJ, Rabkin M, El-Sadr WM, et al
    Clinical decision tools are needed to identify HIV-positive patients at high risk for poor outcomes after initiation of antiretroviral therapy.
    PLoS Med. 2017;14:e1002278.
    >> Share

  48. GENG EH, Peiris D, Kruk ME
    Implementation science: Relevance in the real world without sacrificing rigor.
    PLoS Med. 2017;14:e1002288.
    >> Share

    February 2017
  49. MIKKELSEN E, Hontelez JA, Jansen MP, Barnighausen T, et al
    Evidence for scaling up HIV treatment in sub-Saharan Africa: A call for incorporating health system constraints.
    PLoS Med. 2017;14:e1002240.
    >> Share

  50. BEKKER LG, Gray GE
    Hope for HIV control in southern Africa: The continued quest for a vaccine.
    PLoS Med. 2017;14:e1002241.
    >> Share

    November 2016
  51. MASTERS SH, Agot K, Obonyo B, Napierala Mavedzenge S, et al
    Promoting Partner Testing and Couples Testing through Secondary Distribution of HIV Self-Tests: A Randomized Clinical Trial.
    PLoS Med. 2016;13:e1002166.
    >> Share

  52. FAIRALL LR, Folb N, Timmerman V, Lombard C, et al
    Educational Outreach with an Integrated Clinical Tool for Nurse-Led Non-communicable Chronic Disease Management in Primary Care in South Africa: A Pragmatic Cluster Randomised Controlled Trial.
    PLoS Med. 2016;13:e1002178.
    >> Share

  53. SHUBBER Z, Mills EJ, Nachega JB, Vreeman R, et al
    Patient-Reported Barriers to Adherence to Antiretroviral Therapy: A Systematic Review and Meta-Analysis.
    PLoS Med. 2016;13:e1002183.
    >> Share

    October 2016
  54. KUNKEL A, Cobelens FG, Cohen T
    Tradeoffs in Introduction Policies for the Anti-Tuberculosis Drug Bedaquiline: A Model-Based Analysis.
    PLoS Med. 2016;13:e1002142.
    >> Share

  55. BEYRER C, Makofane K, Orazulike I, Diouf D, et al
    Towards Equity in Service Provision for Gay Men and Other Men Who Have Sex with Men in Repressive Contexts.
    PLoS Med. 2016;13:e1002154.
    >> Share

    September 2016
  56. HORTON KC, MacPherson P, Houben RM, White RG, et al
    Sex Differences in Tuberculosis Burden and Notifications in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.
    PLoS Med. 2016;13:e1002119.
    >> Share

  57. MADANITSA M, Kalilani L, Mwapasa V, van Eijk AM, et al
    Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlle
    PLoS Med. 2016;13:e1002124.
    >> Share

  58. BORQUEZ A, Cori A, Pufall EL, Kasule J, et al
    The Incidence Patterns Model to Estimate the Distribution of New HIV Infections in Sub-Saharan Africa: Development and Validation of a Mathematical Model.
    PLoS Med. 2016;13:e1002121.
    >> Share

  59. MOFENSON LM
    Tenofovir Pre-exposure Prophylaxis for Pregnant and Breastfeeding Women at Risk of HIV Infection: The Time is Now.
    PLoS Med. 2016;13:e1002133.
    >> Share

  60. MUGWANYA KK, Hendrix CW, Mugo NR, Marzinke M, et al
    Pre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant Absorption.
    PLoS Med. 2016;13:e1002132.
    >> Share

    August 2016
  61. ROSEN S, Fox MP, Larson BA, Sow PS, et al
    Accelerating the Uptake and Timing of Antiretroviral Therapy Initiation in Sub-Saharan Africa: An Operations Research Agenda.
    PLoS Med. 2016;13:e1002106.
    >> Share

  62. BINAGWAHO A, Kankindi I, Kayirangwa E, Nyemazi JP, et al
    Transitioning to Country Ownership of HIV Programs in Rwanda.
    PLoS Med. 2016;13:e1002075.
    >> Share

  63. IWUJI CC, Orne-Gliemann J, Larmarange J, Okesola N, et al
    Uptake of Home-Based HIV Testing, Linkage to Care, and Community Attitudes about ART in Rural KwaZulu-Natal, South Africa: Descriptive Results from the First Phase of the ANRS 12249 TasP Cluster-Randomised Trial.
    PLoS Med. 2016;13:e1002107.
    >> Share

  64. BAETEN JM, Heffron R, Kidoguchi L, Mugo NR, et al
    Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda.
    PLoS Med. 2016;13:e1002099.
    >> Share

  65. KILMARX PH, Simbi R
    Progress and Challenges in Scaling Up Laboratory Monitoring of HIV Treatment.
    PLoS Med. 2016;13:e1002089.
    >> Share

  66. HABIYAMBERE V, Ford N, Low-Beer D, Nkengasong J, et al
    Availability and Use of HIV Monitoring and Early Infant Diagnosis Technologies in WHO Member States in 2011-2013: Analysis of Annual Surveys at the Facility Level.
    PLoS Med. 2016;13:e1002088.
    >> Share

  67. JAY J, Buse K, Hart M, Wilson D, et al
    Building from the HIV Response toward Universal Health Coverage.
    PLoS Med. 2016;13:e1002083.
    >> Share

    June 2016
  68. ROSEN S, Maskew M, Fox MP, Nyoni C, et al
    Correction: Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial.
    PLoS Med. 2016;13:e1002050.
    >> Share

  69. ROCHAT TJ, Houle B, Stein A, Coovadia H, et al
    Exclusive Breastfeeding and Cognition, Executive Function, and Behavioural Disorders in Primary School-Aged Children in Rural South Africa: A Cohort Analysis.
    PLoS Med. 2016;13:e1002044.
    >> Share

    May 2016
  70. ROSEN S, Maskew M, Fox MP, Nyoni C, et al
    Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial.
    PLoS Med. 2016;13:e1002015.
    >> Share

  71. MARSEILLE E, Kahn JG
    A Revolution in Treatment for Hepatitis C Infection: Mitigating the Budgetary Impact.
    PLoS Med. 2016;13:e1002031.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016